Samples from a large UK screening trial supported validation of the investigational Evident ovarian cancer test, according to Dawn Mattoon, PhD.
|Videos|December 4, 2022
Part 2: Alternatives to hysterectomy & uterine-preserving options for fibroids
Author(s)Lindsey Carr, Editor
Hear from Kimberly Kho, MD, as she discusses her presentation at AAGL's 51st Global Congress on MIGS in Aurora, Colorado regarding alternatives to hysterectomy and uterine-preserving options for fibroids.
Advertisement
Advertisement
Related to this article
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
Open-ended questions help ob-gyns untangle GSM and low desire and build adherence-focused treatment plans, according to Sheryl Kingsberg, PhD.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Q&A: Peter Hsin, BS, on perioperative ketamine and early postpartum depression
2
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
3
FAQ: Who is a candidate for testosterone therapy in women?
4
FAQ: What does the evidence show about testosterone in women?
5